Collage photo of Koral Shah and Abhishek Tripathi
Jun 8, 2025, 22:13
Koral Shah: Human Epidermal Growth Factor Receptor 2 Testing in Urothelial Carcinoma
Koral Shah, Fellow at City of Hope, shared a post on X:
“HER2 in UC
Vadim Koshkin et al evaluated 2,024 advanced UC tumors for HER2 by IHC and ERBB2 amplification! High HER2 expression (IHC ≥1+) was common—even w/o amplification.
We wrote an editorial published in JCO Precision Oncology to unpack the clinical relevance.”
Title: Human Epidermal Growth Factor Receptor 2 Testing in Urothelial Carcinoma
Authors: Koral U. Shah, Abhishek Tripathi
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 10, 2025, 02:43
Jun 9, 2025, 19:54
Jun 9, 2025, 19:26
Jun 9, 2025, 18:29